LISTED SUPPLIERS
FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ZIPRASIDONE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77565
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210497
Country : US
Patented : No
Drug : PROPRANOLOL HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 70175
Country : US
Patented : No
Drug : METRONIDAZOLE
Dosage Form : TABLET; ORAL
Application Number : 70035
Country : US
Patented : No
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Drug : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : TABLET; ORAL
Application Number : 40729
Country : US
Patented : No
NITROFURANTOIN, MACROCRYSTALLINE
Drug : NITROFURANTOIN
Dosage Form : CAPSULE; ORAL
Application Number : 77025
Country : US
Patented : No
Drug : TACROLIMUS
Dosage Form : CAPSULE; ORAL
Application Number : 206651
Country : US
Patented : No
Drug : COLGATE TOTAL
Dosage Form : PASTE; DENTAL
Application Number : 20231
Country : US
Patented : No
Drug : CIPROFLOXACIN
Dosage Form : TABLET; ORAL
Application Number : 76558
Country : US
Patented : No
Drug : CIPROFLOXACIN HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 76558
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EXCIPIENTS BY APPLICATIONS
Granulation
Application : Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Hydrated Silica
Direct Compression
Application : Direct Compression
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Hydrated Silica
Controlled Modified Release
Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch
Grade : Not Available
Category : Controlled & Modified Release
Application : Controlled & Modified Release
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Hydrated Silica
MARKET PLACE
EXCIPIENTS
Reply
25 Feb 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
LOOKING FOR A SUPPLIER?
Comment (4)
